These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
211 related articles for article (PubMed ID: 19404938)
21. Clinical and radiological outcomes of 5-year drug-free remission-steered treatment in patients with early arthritis: IMPROVED study. Akdemir G; Heimans L; Bergstra SA; Goekoop RJ; van Oosterhout M; van Groenendael JHLM; Peeters AJ; Steup-Beekman GM; Lard LR; de Sonnaville PBJ; Grillet BAM; Huizinga TWJ; Allaart CF Ann Rheum Dis; 2018 Jan; 77(1):111-118. PubMed ID: 28970207 [TBL] [Abstract][Full Text] [Related]
22. Efficacy of initial methotrexate monotherapy versus combination therapy with a biological agent in early rheumatoid arthritis: a meta-analysis of clinical and radiographic remission. Kuriya B; Arkema EV; Bykerk VP; Keystone EC Ann Rheum Dis; 2010 Jul; 69(7):1298-304. PubMed ID: 20421343 [TBL] [Abstract][Full Text] [Related]
23. Disconnect between inflammation and joint destruction after treatment with etanercept plus methotrexate: results from the trial of etanercept and methotrexate with radiographic and patient outcomes. Landewé R; van der Heijde D; Klareskog L; van Vollenhoven R; Fatenejad S Arthritis Rheum; 2006 Oct; 54(10):3119-25. PubMed ID: 17009230 [TBL] [Abstract][Full Text] [Related]
24. Ultrasonographic and radiographic results from a two-year controlled trial of immediate or one-year-delayed addition of infliximab to ongoing methotrexate therapy in patients with erosive early rheumatoid arthritis. Taylor PC; Steuer A; Gruber J; McClinton C; Cosgrove DO; Blomley MJ; Marsters PA; Wagner CL; Maini RN Arthritis Rheum; 2006 Jan; 54(1):47-53. PubMed ID: 16385521 [TBL] [Abstract][Full Text] [Related]
25. [Biologic therapy with anti-TNFα in rheumathoid arthritis]. Ferraccioli G Reumatismo; 2005; 57(4 Suppl):17-21. PubMed ID: 16385351 [TBL] [Abstract][Full Text] [Related]
26. Sustained improvement over two years in physical function, structural damage, and signs and symptoms among patients with rheumatoid arthritis treated with infliximab and methotrexate. Maini RN; Breedveld FC; Kalden JR; Smolen JS; Furst D; Weisman MH; St Clair EW; Keenan GF; van der Heijde D; Marsters PA; Lipsky PE; Arthritis Rheum; 2004 Apr; 50(4):1051-65. PubMed ID: 15077287 [TBL] [Abstract][Full Text] [Related]
27. Rheumatoid arthritis near remission: clinical rather than laboratory inflammation is associated with radiographic progression. Aletaha D; Alasti F; Smolen JS Ann Rheum Dis; 2011 Nov; 70(11):1975-80. PubMed ID: 21803751 [TBL] [Abstract][Full Text] [Related]
28. Effects of adalimumab administration in bio-naïve and bio-switch rheumatoid arthritis patients in daily clinical practice : two-year results from single center. Tashiro Y; Nakashima Y; Okazaki K; Mawatari T; Fukushi J; Ohishi M; Oyamada A; Yamada H; Iwamoto Y Fukuoka Igaku Zasshi; 2013 Nov; 104(11):413-23. PubMed ID: 24620636 [TBL] [Abstract][Full Text] [Related]
29. Etanercept versus methotrexate in patients with early rheumatoid arthritis: two-year radiographic and clinical outcomes. Genovese MC; Bathon JM; Martin RW; Fleischmann RM; Tesser JR; Schiff MH; Keystone EC; Wasko MC; Moreland LW; Weaver AL; Markenson J; Cannon GW; Spencer-Green G; Finck BK Arthritis Rheum; 2002 Jun; 46(6):1443-50. PubMed ID: 12115173 [TBL] [Abstract][Full Text] [Related]
30. Very early treatment with infliximab in addition to methotrexate in early, poor-prognosis rheumatoid arthritis reduces magnetic resonance imaging evidence of synovitis and damage, with sustained benefit after infliximab withdrawal: results from a twelve-month randomized, double-blind, placebo-controlled trial. Quinn MA; Conaghan PG; O'Connor PJ; Karim Z; Greenstein A; Brown A; Brown C; Fraser A; Jarret S; Emery P Arthritis Rheum; 2005 Jan; 52(1):27-35. PubMed ID: 15641102 [TBL] [Abstract][Full Text] [Related]
31. Systematic review and network meta-analysis: effect of biologics on radiographic progression in rheumatoid arthritis. Murray E; Ellis A; Butylkova Y; Skup M; Kalabic J; Garg V J Comp Eff Res; 2018 Oct; 7(10):959-974. PubMed ID: 30129776 [TBL] [Abstract][Full Text] [Related]
32. Evaluation of two strategies (initial methotrexate monotherapy vs its combination with adalimumab) in management of early active rheumatoid arthritis: data from the GUEPARD trial. Soubrier M; Puéchal X; Sibilia J; Mariette X; Meyer O; Combe B; Flipo RM; Mulleman D; Berenbaum F; Zarnitsky C; Schaeverbeke T; Fardellone P; Dougados M Rheumatology (Oxford); 2009 Nov; 48(11):1429-34. PubMed ID: 19741011 [TBL] [Abstract][Full Text] [Related]
33. Patient retention and hand-wrist radiograph progression of rheumatoid arthritis during a 3-year prospective study that prohibited disease modifying antirheumatic drugs. Paulus HE; Di Primeo D; Sharp JT; Genant HK; Weissman BN; Weisman MH; Sanda M; J Rheumatol; 2004 Mar; 31(3):470-81. PubMed ID: 14994390 [TBL] [Abstract][Full Text] [Related]
34. Do Short and Sustained Periods of American College of Rheumatology/European League Against Rheumatism Remission Predict Functional and Radiographic Outcome in Early Rheumatoid Arthritis Patients With Low Overall Damage Progression? Konijn NPC; van Tuyl LHD; Boers M; den Uyl D; Ter Wee MM; Kerstens P; Voskuyl AE; van Schaardenburg D; Nurmohamed MT; Lems WF Arthritis Care Res (Hoboken); 2017 Jul; 69(7):989-996. PubMed ID: 27696732 [TBL] [Abstract][Full Text] [Related]
35. Clinical and Radiographic Outcomes in Patients Diagnosed with Early Rheumatoid Arthritis in the First Years of the Biologic Treatment Era: A 10-year Prospective Observational Study. Haugeberg G; Bøyesen P; Helgetveit K; Prøven A J Rheumatol; 2015 Dec; 42(12):2279-87. PubMed ID: 26568592 [TBL] [Abstract][Full Text] [Related]
36. [Adalimumab (Humira)--efficacy in rheumatoid arthritis treatment with particular reference to working ability]. Grazio S Reumatizam; 2008; 55(2):62-7. PubMed ID: 19024278 [TBL] [Abstract][Full Text] [Related]
37. MRI bone oedema is the strongest predictor of subsequent radiographic progression in early rheumatoid arthritis. Results from a 2-year randomised controlled trial (CIMESTRA). Hetland ML; Ejbjerg B; Hørslev-Petersen K; Jacobsen S; Vestergaard A; Jurik AG; Stengaard-Pedersen K; Junker P; Lottenburger T; Hansen I; Andersen LS; Tarp U; Skjødt H; Pedersen JK; Majgaard O; Svendsen AJ; Ellingsen T; Lindegaard H; Christensen AF; Vallø J; Torfing T; Narvestad E; Thomsen HS; Ostergaard M; Ann Rheum Dis; 2009 Mar; 68(3):384-90. PubMed ID: 18388160 [TBL] [Abstract][Full Text] [Related]
38. Aggressive combination therapy with intra-articular glucocorticoid injections and conventional disease-modifying anti-rheumatic drugs in early rheumatoid arthritis: second-year clinical and radiographic results from the CIMESTRA study. Hetland ML; Stengaard-Pedersen K; Junker P; Lottenburger T; Hansen I; Andersen LS; Tarp U; Svendsen A; Pedersen JK; Skjødt H; Lauridsen UB; Ellingsen T; Hansen GV; Lindegaard H; Vestergaard A; Jurik AG; Østergaard M; Hørslev-Petersen K; Ann Rheum Dis; 2008 Jun; 67(6):815-22. PubMed ID: 17878209 [TBL] [Abstract][Full Text] [Related]
39. Erosive progression is minimal, but erosion healing rare, in patients with rheumatoid arthritis treated with adalimumab. A 1 year investigator-initiated follow-up study using high-resolution computed tomography as the primary outcome measure. Møller Døhn U; Boonen A; Hetland ML; Hansen MS; Knudsen LS; Hansen A; Madsen OR; Hasselquist M; Møller JM; Østergaard M Ann Rheum Dis; 2009 Oct; 68(10):1585-90. PubMed ID: 19019887 [TBL] [Abstract][Full Text] [Related]
40. Adalimumab therapy reduces hand bone loss in early rheumatoid arthritis: explorative analyses from the PREMIER study. Hoff M; Kvien TK; Kälvesten J; Elden A; Haugeberg G Ann Rheum Dis; 2009 Jul; 68(7):1171-6. PubMed ID: 18801760 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]